drugset
drugset / Trial / NCT00394147

Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck Cancer

NCT00394147 ↗

Phase 2 Terminated 17 enrolled Fox Chase Cancer Center Eli Lilly and Company · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to look at how well the combination of two chemotherapy drugs, pemetrexed (Alimta) and gemcitabine (Gemzar) work to treat your cancer.

Timeline

Start
2006-10
Primary completion
2008-08
Completion
2009-12

Outcome

Outcome not reported

Stopped: “stopped for lack of efficacy”

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemcitabine Small molecule 1500 mg/m2 —
Subject Pemetrexed Small molecule 500 mg/m2 —

Indications

head and neck cancer